Dr. Lyn Daws has been named as the next editor of Pharmacological Reviews. Dr. Daws succeeds Dr. Eric Barker. Her three-year term begins January 1, 2022, and runs through December 31, 2024, after which time Dr. Daws will become eligible for a second three-year term.
Dr. Daws is a Frost Bank Distinguished Professor in Biomedical Research and Director of the Physiology and Pharmacology Discipline of the Integrated Biomedical Sciences Graduate Program at the University of Texas Health Science Center at San Antonio.
Dr. Daws has served as Associate Editor for Pharmacological Reviews since 2010. She has also served as guest editor for four other journals and edited a volume of the Handbook of Experimental Pharmacology. Over the years she has served as an ad hoc reviewer for almost 40 journals.
As of this writing, she has published 73 research articles and she has also written 29 editorials, reviews, and book chapters.